Renaissance Technologies - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$328,000
-55.1%
90,200
-38.5%
0.00%
-100.0%
Q1 2021$730,000
+173.4%
146,590
+163.7%
0.00%
Q2 2020$267,000
-7.0%
55,594
+0.7%
0.00%
Q1 2020$287,000
-12.8%
55,196
+68.3%
0.00%
Q4 2019$329,00032,7960.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,346,601$12,182,0000.22%
Parkman Healthcare Partners LLC 75,647$275,0000.06%
Sterling Financial Planning, Inc. 1,171$4,0000.00%
Newbridge Financial Services Group, Inc. 1,000$4,0000.00%
UBS Group AG 399$1,0000.00%
TWO SIGMA INVESTMENTS, LP 27,061$99,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$10,0000.00%
WELLS FARGO & COMPANY/MN 40$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders